Indolizine: a biologically active moiety

被引:219
作者
Sharma, Vikas [1 ]
Kumar, Vipin [1 ]
机构
[1] Kurukshetra Univ, Inst Pharmaceut Sci, Kurukshetra 136119, Haryana, India
关键词
Biologically active; Camptothecin; Derivative; Heterocyclic; Indolizine; Moiety; Review; AFFINITY NA+/GLUCOSE COTRANSPORTER; PRODUCT-DERIVED COMPOUNDS; IN-VITRO; PHOSPHODIESTERASE-4; INHIBITORS; ANTINOCICEPTIVE ACTION; ANTITUMOR-ACTIVITY; POTENT INHIBITORS; NATURAL-PRODUCTS; BREAST-CANCER; DERIVATIVES;
D O I
10.1007/s00044-014-0940-1
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The discovery of camptothecin and its analogs was the major breakthrough through which "Indolizine moiety" came into limelight. Although major part of the research on indolizine derivatives is focused on anticancer drug discovery, these derivatives have also been screened for different biological activities such as antitubercular, antioxidant, antimicrobial, anticancer, and anti-inflammatory activities to name a few. Despite being an important medicinal moiety, a detailed review on the biologically active potential of indolizine derivative is unavailable. To the best of our knowledge, previous reviews on indolizine derivatives mainly focused on their chemistry and synthesis. The present review discusses the versatile nature of indolizine derivatives and their possible mechanism of action. Important SAR points are discussed with each study to highlight the rationale behind the study. Furthermore, the present review also provides information about current/future prospects of the topic and different indolizine derivatives in clinical trials.
引用
收藏
页码:3593 / 3606
页数:14
相关论文
共 100 条
[1]  
Abele E, 2003, KHIM GETEROTSIKL+, P963
[2]  
[Anonymous], 2002, E PESTICIDE MANUAL V
[3]  
[Anonymous], 2004, CHEM HETEROCYC COMPO, DOI DOI 10.1023/B:COHC.0000023761.76443.34
[4]  
[Anonymous], 2000, PESTICIDE MANUAL
[5]  
[Anonymous], EXPERT OPIN THER PAT
[6]  
[Anonymous], POSTMENOPAUSAL STATE
[7]  
[Anonymous], DIFL BN80915 ADM ONC
[8]  
[Anonymous], 2009, Sci. Pharm.
[9]  
[Anonymous], 2011, Int. J. Pharm. Sci. Rev. Res
[10]  
[Anonymous], PHARM MED